These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 6139800

  • 1. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ, High J, DeForrest JM, Sybertz E.
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [Abstract] [Full Text] [Related]

  • 3. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
    Man in 't Veld AJ, Schalekamp MA.
    Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
    [Abstract] [Full Text] [Related]

  • 4. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A, Man in't Veld AJ, van Eck HR, Wenting GJ, Schalekamp MA.
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC, Dustan HP, Bravo EL.
    Postgrad Med J; 1976 Dec; 52 Suppl 4():92-100. PubMed ID: 787955
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA, Stokes GS, Gain JM.
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in't Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MA.
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [Abstract] [Full Text] [Related]

  • 8. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN, Owens CW.
    Clin Physiol Biochem; 1990 Oct; 8 Suppl 2():1-10. PubMed ID: 1982756
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 10. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL.
    J Cardiovasc Pharmacol; 1983 Jun; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [Abstract] [Full Text] [Related]

  • 11. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC, Kriek E, van Brummelen P.
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [Abstract] [Full Text] [Related]

  • 12. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
    Philipp T, Cordes U, Distler A.
    Dtsch Med Wochenschr; 1977 Apr 15; 102(15):569-74. PubMed ID: 14816
    [Abstract] [Full Text] [Related]

  • 13. Bucindolol in essential hypertension.
    Reid JL, Curzio J, Vincent J.
    Int J Clin Pharmacol Res; 1985 Apr 15; 5(5):293-301. PubMed ID: 2866166
    [Abstract] [Full Text] [Related]

  • 14. Beta blockers and renal function: a reappraisal.
    Epstein M, Oster JR.
    J Clin Hypertens; 1985 Mar 15; 1(1):85-99. PubMed ID: 2873206
    [Abstract] [Full Text] [Related]

  • 15. [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)].
    Plouin PF, Comoy E, Bohuon C, Corvol P, Ménard J.
    Nouv Presse Med; 1979 May 26; 8(23):1905-9. PubMed ID: 461152
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in 't Veld AJ, van Eck HJ, Boomsma F, Schalekamp MA.
    Circulation; 1988 Oct 26; 78(4):957-68. PubMed ID: 3048776
    [Abstract] [Full Text] [Related]

  • 17. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL, Tarazi RC, Dustan HP.
    N Engl J Med; 1975 Jan 09; 292(2):66-70. PubMed ID: 234005
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S, Eich RH, Obeid AI, Smulyan H.
    Arch Intern Med; 1977 Mar 09; 137(3):290-5. PubMed ID: 843147
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H, Julius S.
    Fed Proc; 1984 Jan 09; 43(1):67-71. PubMed ID: 6317465
    [Abstract] [Full Text] [Related]

  • 20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 09; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.